細胞学の世界市場2018-2022

◆英語タイトル:Global Cytology Market 2018-2022
◆商品コード:IRTNTR23806
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年11月28日
◆ページ数:115
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、細胞学の世界市場について調査・分析し、市場概要、市場環境、細胞学市場規模、製品別(測定キット、システム)分析、エンドユーザー別(病院・診療所、調査研究所・学術機関、その他)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・細胞学の世界市場概要
・細胞学の世界市場環境
・細胞学の世界市場動向
・細胞学の世界市場規模
・細胞学の世界市場:業界構造分析
・細胞学の世界市場:製品別(測定キット、システム)
・細胞学の世界市場:エンドユーザー別(病院・診療所、調査研究所・学術機関、その他)
・細胞学の世界市場:地域別市場規模・分析
・細胞学の北米市場規模・予測
・細胞学のヨーロッパ・中東・アフリカ市場規模・予測
・細胞学のアジア太平洋市場規模・予測
・細胞学の主要国分析
・細胞学の世界市場:意思決定フレームワーク
・細胞学の世界市場:成長要因、課題
・細胞学の世界市場:競争環境
・細胞学の世界市場:関連企業情報(ベンダー分析)

主な分析対象企業は、Abbott、B.D、F. Hoffmann-La Roche、Hologic、Thermo Fisher Scientific、Trivitron Healthcareなどです。
【レポートの概要】

About this market
The screening of cervical cancer has reduced the morbidity and mortality drastically. Pap test is used as a screening tools for cervical cancer has improved detection of cervical intraepithelial neoplasia. Furthermore, increasing prevalence of HPV- associated cancers is likely to drive the market. Therefore, a substantial increase of HPV- associated cancers propels the demand for cytology testing and screenings methods. Furthermore, co- testing help manage women who have low grade abnormal cells changes. Technavio’s market research analysts have predicted that the cytology market will register a CAGR of nearly 7% by 2022.
Market Overview
Growing cervical cancer screening awareness
Cervical cancer is the most common in developing as well as developing countries. It is mainlpy caused by human papillomavirus infection. Screening of cervical cancerous cells in mainly done by using liquid- based cytology test and pap smear test. The increasing prevalence of cervical cancer cases have increased the demand for cytology testing.
Factors affecting adequacy of test
Poor fixation, techniques, inflammatory changes, and cellular changes related to radiation may obscure cellar and misinterpret at the result. This had led to false positive diagnostics can occur in case of pregnancy, contamination of the sample, and others. Such factors will affect the adequacy of the test result an d hence negatively affect the market.
For the detailed list of factors that will drive and challenge the growth of the cytology market during the 2018-2022, view our report.
Competitive Landscape
The global cytology market is extremely concentrated with the presence of few companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY PRODUCT
• Assay kits
• Systems
PART 09: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Hospitals and clinics – Market size and forecast 2017-2022
• Research laboratories and academic institutes– Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by end-user
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Growing popularity of co-testing
• Consolidation and automation of laboratories
• Advent of cytology imaging systems
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• BD
• F. Hoffmann-La Roche 1
• Hologic
• Thermo Fisher Scientific
• Trivitron Healthcare
PART 16: APPENDIX
• List of abbreviations



Exhibit 01: Global laboratory equipment market
Exhibit 02: Global laboratory equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global cytology market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global cytology market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Customer landscape
Exhibit 19: Global cytology market by product 2017 (%)
Exhibit 20: End-user – Market share 2017-2022 (%)
Exhibit 21: Comparison by end-user
Exhibit 22: Hospitals and clinics – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Hospitals and clinics – Year-over-year growth 2018-2022 (%)
Exhibit 24: Research laboratories and academic institutes – Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Research laboratories and academic institutes – Year-over-year growth 2018-2022 (%)
Exhibit 26: Others– Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Others – Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by end-user
Exhibit 29: Global – Market share by geography 2017-2022 (%)
Exhibit 30: Regional comparison
Exhibit 31: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top three countries in Americas
Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top three countries in EMEA
Exhibit 37: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 38: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 39: Top three countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott: Overview
Exhibit 47: Abbott – Business segments
Exhibit 48: Abbott– Organizational developments
Exhibit 49: Abbott– Geographic focus
Exhibit 50: Abbott – Segment focus
Exhibit 51: Abbott – Key offerings
Exhibit 52: BD: Overview
Exhibit 53: BD– Business segments
Exhibit 54: BD – Organizational developments
Exhibit 55: BD– Geographic focus
Exhibit 56: BD – Segment focus
Exhibit 57: BD – Key offerings
Exhibit 58: F. Hoffmann-La Roche: Overview
Exhibit 59: F. Hoffmann-La Roche – Business segments
Exhibit 60: F. Hoffmann-La Roche – Organizational developments
Exhibit 61: F. Hoffmann-La Roche – Geographic focus
Exhibit 62: F. Hoffmann-La Roche – Segment focus
Exhibit 63: F. Hoffmann-La Roche – Key offerings
Exhibit 64: Hologic: Overview
Exhibit 65: Hologic – Business segments
Exhibit 66: Hologic– Organizational developments
Exhibit 67: Hologic– Geographic focus
Exhibit 68: Hologic – Segment focus
Exhibit 69: Hologic – Key offerings
Exhibit 70: Thermo Fisher Scientific: Overview
Exhibit 71: Thermo Fisher Scientific – Business segments
Exhibit 72: Thermo Fisher Scientific– Organizational developments
Exhibit 73: Thermo Fisher Scientific– Geographic focus
Exhibit 74: Thermo Fisher Scientific– Segment focus
Exhibit 75: Thermo Fisher Scientific– Key offerings
Exhibit 76: Trivitron Healthcare: Overview
Exhibit 77: Trivitron Healthcare– Business segments
Exhibit 78: Trivitron Healthcare– Organizational developments
Exhibit 79: Trivitron Healthcare – Key offerings



【掲載企業】

Abbott、B.D、F. Hoffmann-La Roche、Hologic、Thermo Fisher Scientific、Trivitron Healthcare

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[細胞学の世界市場2018-2022]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆